Investment analysts at Wedbush initiated coverage on shares of Huron Consulting Group (NASDAQ:HURN – Get Free Report) in a report released on Monday. The firm set an “outperform” rating on the business services provider’s stock.
Several other research firms also recently weighed in on HURN. StockNews.com raised Huron Consulting Group from a “hold” rating to a “buy” rating in a research report on Thursday, October 31st. Benchmark reaffirmed a “buy” rating and issued a $140.00 price objective on shares of Huron Consulting Group in a research report on Wednesday, October 30th. Finally, Barrington Research upped their price objective on Huron Consulting Group from $137.00 to $142.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat, Huron Consulting Group has a consensus rating of “Buy” and a consensus target price of $133.00.
View Our Latest Stock Analysis on HURN
Huron Consulting Group Price Performance
Insider Buying and Selling at Huron Consulting Group
In other Huron Consulting Group news, Director James H. Roth sold 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $128.42, for a total value of $256,840.00. Following the sale, the director now directly owns 54,825 shares of the company’s stock, valued at approximately $7,040,626.50. This trade represents a 3.52 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John Mccartney sold 500 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $124.65, for a total value of $62,325.00. Following the completion of the transaction, the director now owns 56,688 shares in the company, valued at approximately $7,066,159.20. This trade represents a 0.87 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 7,542 shares of company stock worth $941,913. 2.20% of the stock is owned by insiders.
Hedge Funds Weigh In On Huron Consulting Group
Institutional investors have recently added to or reduced their stakes in the stock. Heck Capital Advisors LLC purchased a new stake in Huron Consulting Group in the fourth quarter valued at $33,000. Assetmark Inc. raised its position in Huron Consulting Group by 7.0% in the third quarter. Assetmark Inc. now owns 1,373 shares of the business services provider’s stock valued at $149,000 after purchasing an additional 90 shares during the period. MML Investors Services LLC purchased a new stake in Huron Consulting Group in the third quarter valued at $220,000. Peapack Gladstone Financial Corp purchased a new stake in Huron Consulting Group in the third quarter valued at $220,000. Finally, Dakota Wealth Management raised its position in Huron Consulting Group by 4.0% in the fourth quarter. Dakota Wealth Management now owns 2,250 shares of the business services provider’s stock valued at $280,000 after purchasing an additional 87 shares during the period. Hedge funds and other institutional investors own 93.90% of the company’s stock.
Huron Consulting Group Company Profile
Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.
See Also
- Five stocks we like better than Huron Consulting Group
- When to Sell a Stock for Profit or Loss
- Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now
- What is an Earnings Surprise?
- Big Dividend Hikes: 4 Large-Cap Stocks Increasing Payouts
- What is a support level?
- Procter & Gamble: A Consumer Staples Titan Built to Win
Receive News & Ratings for Huron Consulting Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huron Consulting Group and related companies with MarketBeat.com's FREE daily email newsletter.